A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months

[1] Druker BJ(2006)Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408-2417

[2] Guilhot F(2002)Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472-480

[3] O’Brien SG(2006)Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate Leukemia 20 1162-1164

[4] Gathmann I(2003)Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis J Clin Oncol 21 3171-3173

[5] Kantarjian H(2008)Pulmonary complications of novel antineoplastic agents for solid tumors Chest 133 528-538

[6] Gattermann N(1991)Acute lung injury. Pathogenesis of intraalveolar fibrosis J Clin Invest 88 663-673

[7] Demetri GD(1993)Variable expression of platelet-derived growth factor family proteins in acute lung injury Am J Respir Cell Mol Biol 9 637-644

[8] von Mehren M(2002)Hypersensitivity pneumonitis related to imatinib mesylate J Clin Oncol 20 4271-4272

[9] Blanke CD(2005)Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy Am J Hematol 79 80-81

[10] Van den Abbeele AD(2004)Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration Leukemia 18 645-646

[1] Druker BJ(2006)Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408-2417

[2] Guilhot F(2002)Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472-480

[3] O’Brien SG(2006)Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate Leukemia 20 1162-1164

[4] Gathmann I(2003)Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis J Clin Oncol 21 3171-3173

[5] Kantarjian H(2008)Pulmonary complications of novel antineoplastic agents for solid tumors Chest 133 528-538

[6] Gattermann N(1991)Acute lung injury. Pathogenesis of intraalveolar fibrosis J Clin Invest 88 663-673

[7] Demetri GD(1993)Variable expression of platelet-derived growth factor family proteins in acute lung injury Am J Respir Cell Mol Biol 9 637-644

[8] von Mehren M(2002)Hypersensitivity pneumonitis related to imatinib mesylate J Clin Oncol 20 4271-4272

[9] Blanke CD(2005)Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy Am J Hematol 79 80-81

[10] Van den Abbeele AD(2004)Interstitial pneumonia induced by imatinib mesylate: pathologic study demonstrates alveolar destruction and fibrosis with eosinophilic infiltration Leukemia 18 645-646